Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lesleigh S. Abbott"'
Autor:
Sandra Judd, Gabriel Revon‐Riviere, Stephanie A. Grover, Rebecca J. Deyell, Magimairajan Issai Vanan, Victor A. Lewis, Lucie Pecheux, Alexandra P. Zorzi, Catherine Goudie, Raoul Santiago, Thai Hoa Tran, Lesleigh S. Abbott, Josee Brossard, Paul Moorehead, Saima Alvi, Carol Portwine, Avram Denburg, James A. Whitlock, Sarah Cohen‐Gogo, Daniel A. Morgenstern
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Background The need for new therapies to improve survival and outcomes in pediatric oncology along with the lack of approval and accessible clinical trials has led to “out‐of‐trial” use of innovative therapies. We conducted a retrosp
Externí odkaz:
https://doaj.org/article/ed6f3e4aa5bc4ea2ad6a15650609498b
Autor:
Nacera Hanzal, Jenna Yaraskavitch, Patricia E. Longmuir, Anna M. McCormick, Jane Lougheed, Christine Lamontagne, Kristian B. Goulet, Leanne M. Ward, Sherri L. Katz, Marie-Eve Robinson, Lesleigh S. Abbott, Thomas A. Kovesi, John J. Reisman, Daniela Pohl, Hana Alazem
Publikováno v:
Exercise Medicine, Vol 7 (2023)
Objectives To enhance the confidence of children and adolescents with medical conditions and disabilities to engage in healthy, active lifestyles. Children with medical conditions and disabilities often exhibit more sedentary lifestyles relative to p
Externí odkaz:
https://doaj.org/article/25a30235816a4807a8fbbe118d97ea86
Publikováno v:
Cancer Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
Abstract Background Adolescents and young adults with cancer (AYA) are a complex group of patients. The development of fever and neutropenia (FN) is a potentially lethal complication of chemotherapy. Risk stratification of patients with FN has become
Externí odkaz:
https://doaj.org/article/8e42e4bdf3b348c8a35e016810855928
Autor:
Alison M. R. Castle, Brianna Empringham, Lisa M Pinto, Anita Villani, Nisha Kanwar, Lesleigh S. Abbott, Sarah L Sawyer
Publikováno v:
Pediatric Hematology and Oncology. :1-10
Publikováno v:
Cancer Reports. 6
Background: Adolescents and young adults with cancer (AYA) are a complex group of patients. The development of fever and neutropenia (FN) is a potentially lethal complication of chemotherapy. Risk stratification of patients with FN has become increas
Autor:
Yigal Dror, Tal Schechter, Michaela Cada, Robert J. Klaassen, Iren Shabanova, Elaine W. Leung, Donna L. Johnston, Lesleigh S. Abbott
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:170-174
The distinction between myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) often relies on an arbitrary marrow blast cutoff of 30% in pediatrics and 20% in adults. There is little data about the treatment of children with extramedullary
Autor:
Nagwa Wilson, Cassandra Kapoor, Barry Smith, Gali Shapira-Zaltsberg, Stephen Dinning, Esther Trejo Perez, Jorge Davila, Elka Miller, Lesleigh S Abbott
Publikováno v:
Canadian Association of Radiologists Journal. 71:217-225
Purpose: The aim of our study was to compare whole-body diffusion-weighted MRI (WB-DWI-MRI) to fluoro-2-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the assessment of initial staging and treatment response in pediatri
Publikováno v:
Pediatric Blood & Cancer. 68
Publikováno v:
BMJ Case Rep
A 12-year-old girl was diagnosed with acute myeloid leukaemia (AML) with cytogenetics showing inv(14)(q11.2q32). Cerebrospinal fluid (CSF) was negative for leukaemia. She was treated based on Children’s Oncology Group protocol AAML1031 with an Medi
Publikováno v:
Pediatric Drugs. 15:473-492
The Ewing sarcoma family of tumors (ESFT) is defined by cell surface expression of CD99 and a translocation involving EWS and an ETS partner. Cytotoxic chemotherapy remains the benchmark of first- and second-line therapy, and although the majority of